I am by no means negative on MSB, and Have held for some time, but cannot see the lack of interested parties to GVHD as a good outcome. I am yet to read a constructive comment that addresses the elephant in the room here..... another company has MSC in trial for GVHD that appear to more efficacious and far cheaper to produce, and they have already partnered. It is quite possible given the fast track processs of regen medicine they could be in market before 2020. This could explain why no one has been interested in MSBs GVHD cells..... they may not have a market for long.... I don’t like this loan!
Add to My Watchlist
What is My Watchlist?
